Keywords HbS/D-Punjab disease Á Hydroxyurea Á Clinical spectrum Double heterozygosity for sickle cell ? Hb D-Pubjab is a rare symptomatic hemoglobinopathy arising from biallelic mutations of the HBB gene. One allele produces HbS while other allele is producing HbD-Punjab. p.Glu6Val mutation in HBB codes for HbS and p.Glu121Gln mutation codes for HbD-Punjab. [1] . Clinical manifestations of sickle cell HbSD-Pubjab exhibit slightly milder outcome compared to common sickle cell anemia (HbSS). However, Splenomegaly is more common in HbSD-Punjab than in HbSS disease [2] . Elevated blood HbF level is known to be protective against HbSS disease which minimizes the severity and the complications. Hydroxyurea is an inducer of HbF. For sickle cell HbSD-Pubjab disease, the results of hydroxyurea treatment are yet to be established. A single centre study found elevated HbF level related to a protective effect following hydroxyurea treatment for sickle cell HbSDPubjab disease [3] . We describe here, our experiences with 3 HbSD-Punjab patients, 2 of whom/all 3 were treated with hydroxyurea.
A 10-year-old girl presented with having 12 episodes dyspnoea and fever where most episodes required pediatric intensive care and ventilator support (Case-1). These episodes were associated with haemoglobin counts of less than 6 g/dl, and numerous amounts of sickle cells (90%) in the blood picture. She had been diagnosed as having sickle cell HbSD-Pubjab disease at 1y of age by High Performance Liquid Chromatography (Table 1) . Her chest x-ray was suggestive of sickle chest syndrome. After introducing hydroxyurea 500 mg daily, her HbF level increased up to 25% and during 18 months of follow-up and she remained healthy.
A 16-year-old boy who is the elder brother of the girl in case-1 was diagnosed as having Sickle cell HbSD disease at the age of 7 y by routine family screening (Case-2). He had two episodes of painful limping and three episodes of right sided focal seizures. Both of these episodes were associated with low haemoglobin levels (6.5 g/dl) and 70% of sickle cells in blood picture (Table 1) . X-ray of the right hip showed a vascular necrosis. After introducing hydroxyurea, 500 mg daily, HbF level increased up to 25% and during 18 months of follow-up, he remained healthy.
A 22-year-old Caucasian male, drew medical attention because of incidental finding of jaundice at the age of 18 y (Case-3). His full blood count showed Hb: 8.2 g/dL and blood picture showed features of sickle cell disease including mild polychromasia and Howel-Jolly bodies which indicates auto splenectomy. The ultrasound examination of the abdomen showed multiple gall stones. He was not on hydroxyuria therapy. Many epidemiologic studies suggested that disease complications most closely linked to vaso-occlusion and blood viscosity [4] . Here, in case-1 and case-2 their complications were associated with vaso-occlusion. When the total HbF concentration is near 25-30%, it is possible for the number of ''protected cells'' to approach 70% which can suppress the clinical symptoms [5] . Since case-3 was an incidental finding and was asymptomatic we haven't introduced hydroxyurea. Further, case-1 showed most severe clinical presentation and case-2 was milder than case-1 while case-3 had the least severity. This indicates the phenotypic heterogeneity and the reason behind would be having gene-gene interactions.
These 3 cases highlight that clinical manifestations showing mild to severe form of HbS/D-Punjab disease which indicate the phenotypic heterogeneity. Also, use of hydroxyurea which is a HbF inducer suppresses the severity of clinical manifestations of the HbS/D-Punjab disease which is a rare form of sickle cell anemia.
